Vitamin D and Cognition Study (VITA-D)
Study background
Australia's population is ageing rapidly and so is the frequency of age-related health problems, such as cognitive decline and dementia. Mild Cognitive Impairment (MCI) describes mild memory problems in older adults that are associated with an increased risk of future cognitive decline. There is increasing evidence that cognitive decline can be delayed by targeting potentially modifiable risk factors. Vitamin D is important for healthy bones and muscle function, but is also possibly important for healthy brain function. The purpose of this randomised placebo-controlled clinical trial is to investigate whether supplementation with vitamin D for 18 months in older adults with MCI who have low vitamin D levels, can help to reduce future cognitive decline. Our researchers are currently looking at the study results and hope to publish the results in the next 6-8 months.
Further information
PDF 0.2MB ]